Guilin Kevin Peter Technology Co., Ltd. has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Dental Diode Laser Device, marketed as the Laser-Pen. The clearance was granted on September 18, 2026, affirming the device's substantial equivalence to predicate devices already on the market.
This regulatory approval allows for the commercial distribution of the Laser-Pen within the United States. The device falls under product code GEX, which corresponds to laser surgical instruments for general use and plastic surgery, and is classified as a Class II medical device under regulation number 878.4810.
Regulatory Pathway and Device Classification
The FDA's decision followed a Traditional 510(k) submission, a common premarket notification pathway for devices that can demonstrate substantial equivalence to a legally marketed predicate device. This pathway typically involves comparing the new device's indications for use, technological characteristics, and performance data to those of the predicate device to ensure safety and effectiveness.
The Dental Diode Laser Device is intended for use in general and plastic surgery, as indicated by its advisory committee classification. Further details regarding specific clinical indications or technological specifications beyond what is standard for dental diode lasers have not been publicly disclosed by the FDA or the manufacturer at the time of this report.
The substantial equivalence determination signals that the FDA found the Laser-Pen to be as safe and effective as existing dental laser technologies.
Market Implications and Unspecified Details
While the FDA clearance provides market access, specific details regarding the device's launch, pricing, or detailed clinical data supporting its efficacy beyond the regulatory submission summary are not yet available. Guilin Kevin Peter Technology Co., Ltd. has not publicly released further information regarding the device's commercial strategy or comparative advantages. The competitive landscape for dental diode lasers is established, with several manufacturers already offering similar technologies.
The clearance does not inherently provide information on the device's impact on treatment protocols or patient outcomes, beyond the general understanding that approved devices meet FDA standards for safety and effectiveness for their indicated uses.
